Titre (en)
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Titre (en) » - entrée « cancer »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
campaign < cancer < cancers  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000010 (2020) Aline Pfefferle [Australie] ; Nicholas D. Huntington [Australie]You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
000027 (2020) Shanshan Deng [États-Unis, République populaire de Chine] ; Michael J. Clowers [États-Unis] ; Walter V. Velasco [États-Unis] ; Marco Ramos-Castaneda [États-Unis] ; Seyed Javad Moghaddam [États-Unis]Understanding the Complexity of the Tumor Microenvironment in K-ras Mutant Lung Cancer: Finding an Alternative Path to Prevention and Treatment
000080 (2020) Maria Valeria Catani ; Isabella Savini ; Valentina Tullio ; Valeria GasperiThe “Janus Face” of Platelets in Cancer
000086 (2020) Christine Brostjan ; Rudolf OehlerThe role of neutrophil death in chronic inflammation and cancer
000087 (2020) Wanhai Ke ; Li Zhang ; Yan DaiThe role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs)
000089 (2020) Jacob J. Adashek [États-Unis] ; Shumei Kato [États-Unis] ; Scott M. Lippman [États-Unis] ; Razelle Kurzrock [États-Unis]The paradox of cancer genes in non-malignant conditions: implications for precision medicine
000122 (2020) Timothy M. Smith ; Anuj Tharakan ; Rebecca K. MartinTargeting ADAM10 in Cancer and Autoimmunity
000158 (2020) Qingyun Zhu [République populaire de Chine] ; Yingying Shen [République populaire de Chine] ; Xiguang Chen [République populaire de Chine] ; Jun He [République populaire de Chine] ; Jianghua Liu [République populaire de Chine] ; Xuyu Zu [République populaire de Chine]Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells
000170 (2020) Renba Liang ; Xishan Chen ; Li Chen ; Fangzhu Wan ; Kaihua Chen ; Yongchu Sun ; Xiaodong ZhuSTAT3 signaling in ovarian cancer: a potential therapeutic target
000273 (2020) Zheng Wang [États-Unis] ; Yicheng Zhao [États-Unis] ; Zhiqiang An [États-Unis] ; Wenliang Li [États-Unis]Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
000279 (2020) Stefan Poschner ; Judith Wackerlig ; Dan Cacsire Castillo-Tong ; Andrea Wolf ; Isabel Von Der Decken ; Tea Lanišnik Rižner ; Renata Pavli ; Anastasia Meshcheryakova ; Diana Mechtcheriakova ; Monika Fritzer-Szekeres ; Theresia Thalhammer ; Walter J Ger [Autriche]Metabolism of Estrogens: Turnover Differs between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells
000285 (2020) Ling Peng [République populaire de Chine] ; Sladjana Zagorac [Royaume-Uni] ; Justin Stebbing [Royaume-Uni]Managing patients with cancer in the COVID-19 era
000374 (2020) Tolu Omokehinde [États-Unis] ; Rachelle W. Johnson [États-Unis]GP130 Cytokines in Breast Cancer and Bone
000394 (2020) Alberto Meneguzzo ; Annalisa Lazzarotto ; Mauro AlaibacEruptive Melanocytic Nevi Secondary to Encorafenib for BRAF Mutant Metastatic Colorectal Cancer
000462 (2020) Renate U. Wahl ; Marike Leijs [Belgique] ; Arturo Araujo [Royaume-Uni] ; Albert RübbenCorrelative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer
000510 (2020) Daniel Sur ; Andrei Havasi ; Calin Cainap ; Gabriel Samasca ; Claudia Burz ; Ovidiu Balacescu [Roumanie] ; Iulia Lupan [Roumanie] ; Diana Deleanu ; Alexandru Irimie [Roumanie]Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer
000541 (2020) Cindy B. Yeoh ; Kathleen J. Lee ; Elizabeth F. Rieth ; Renee Mapes ; Anna V. Tchoudovskaia ; Gregory W. Fischer ; Luis E. TollincheCOVID-19 in the Cancer Patient
000620 (2019) Surinder M. Soond [Russie] ; Maria V. Kozhevnikova ; Paul A. Townsend ; Andrey A. Zamyatnin [Russie]Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer
000625 (2013) Katsutoshi Ando [Japon] ; Fumiyuki Takahashi ; Shinji Motojima ; Kei Nakashima ; Norihiro Kaneko ; Kazuei Hoshi ; Kazuhisa TakahashiPossible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia.
000631 (????) Elie Rassy [Liban] ; Rita-Maria Khoury-Abboud [Liban] ; Nathalie Ibrahim [Liban] ; Clarisse Kattan [Liban] ; Tarek Assi [Liban] ; Joseph Kattan [Liban]What the oncologist needs to know about COVID-19 infection in cancer patients

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "cancer" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "cancer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    cancer
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021